CORC

浏览/检索结果: 共16条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis 期刊论文
CUTANEOUS AND OCULAR TOXICOLOGY, 2019, 卷号: 38, 期号: 2
作者:  Chen, Peng;  Chen, Fucaho;  Zhou, Benhong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation 期刊论文
Journal of Cellular Biochemistry, 2019, 卷号: Vol.120 No.4, 页码: 5315-5325
作者:  Kai Wang;  Yanrong Li;  Na Song;  Xiaofang Che;  Kezuo Hou
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/17
The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma 期刊论文
TARGETED ONCOLOGY, 2018, 卷号: 13, 期号: 4
作者:  Liu, Xiao;  Wu, Jinfeng;  Qin, Haihong;  Xu, Jinhua
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition 期刊论文
CANCER LETTERS, 2017, 卷号: 406, 页码: 105-115
作者:  Sun, Danni;  Liu, Hongchun;  Dai, Xiaoyang;  Zheng, Xingling;  Yan, Juan
收藏  |  浏览/下载:48/0  |  提交时间:2019/01/08
AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes 期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 卷号: 489, 期号: 1, 页码: 14-20
作者:  Wang, Hongbin;  Quan, Haitian;  Lou, Liguang
收藏  |  浏览/下载:26/0  |  提交时间:2019/01/08
Polymeric Immunoglobulin Receptor Promotes Tumor Growth in Hepatocellular Carcinoma 期刊论文
HEPATOLOGY, 2017, 卷号: 65, 期号: 6, 页码: 1948-1962
作者:  Yue, Xihua;  Ai, Jing;  Xu, Yang;  Chen, Yi;  Huang, Min
收藏  |  浏览/下载:35/0  |  提交时间:2019/01/08
Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth 期刊论文
ONCOGENE, 2017, 卷号: 36, 期号: 6, 页码: 756-765
作者:  Piao, H-I;  Wang, Y.;  Hong, X.;  Wang, J.;  Yin, Y.
收藏  |  浏览/下载:25/0  |  提交时间:2019/06/20
Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 3, 页码: 5003-5015
作者:  Song, Qiaoling;  Sun, Xiaoxiao;  Guo, Hui;  Yu, Qiang
收藏  |  浏览/下载:20/0  |  提交时间:2019/01/08
ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells via induction of ER stress and inhibition of ERK activation 期刊论文
ONCOLOGY REPORTS, 2017, 卷号: 37, 期号: 2
作者:  Peng, Ueihuei;  Wang, Zhihao;  Pei, Sa;  Ou, Yunchao;  Hu, Pengchao
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis 期刊论文
ONCOTARGETS AND THERAPY, 2017, 卷号: 10
作者:  Chen, Peng;  Chen, Fuchao;  Zhou, Benhong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace